5-[2H-Pyrrol-4-(3H)-ylidenemethyl]-2-furanmethanol

Metabolite details

Identifier

JOWOWIZUAITHGQ-YVMONPNESA-N

InChI Key

JOWOWIZUAITHGQ-YVMONPNESA-N

IUPAC name

[5-[(Z)-2,3-dihydropyrrol-4-ylidenemethyl]uran-2-yl]methanol

Preferred name

5-[2H-Pyrrol-4-(3H)-ylidenemethyl]-2-furanmethanol

INN name

—

Synonym

—

ChEBI

CHEBI:178977

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day
• Control_0d_vs_Treatment_180d